Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases
Annals of Surgical Oncology1996Vol. 3(1), pp. 44–50
Citations Over TimeTop 10% of 1996 papers
Related Papers
- → Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis(2007)65 cited
- → Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment or Prevention of Peritoneal Carcinomatosis(2004)13 cited
- [Intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinosis of digestive origin. A case report and physiopathology].(1990)
- Animal experiments as a model for clinical trials of a new dosage form of mitomycin C for peritoneal carcinomatosis.(1992)
- → Reiterated hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinosis: Our single-center experience(2012)